Ethyl 4-Chloro-3-Hydroxybutanoate CAS 10488-69-4 Assay ≥98.0% (GC) High Purity

Short Description:

Chemical Name: Ethyl 4-Chloro-3-Hydroxybutanoate

CAS: 10488-69-4

Appearance: Colorless to Pale Yellow Liquid

Assay: ≥98.0% (GC)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply with High Purity and Stable Quality
Ethyl 4-Chloro-3-Hydroxybutanoate CAS 10488-69-4
Ethyl (S)-4-Chloro-3-Hydroxybutyrate CAS 86728-85-0
Ethyl (R)-(+)-4-Chloro-3-Hydroxybutyrate CAS 90866-33-4
Chiral Compounds, High Quality, Commercial Production

Chemical Properties:

Chemical Name	Ethyl 4-Chloro-3-Hydroxybutanoate
Synonyms	DL-Ethyl 4-Chloro-3-Hydroxybutyrate
CAS Number	10488-69-4
CAT Number	RF-CC187
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C6H11ClO3
Molecular Weight	166.6
Melting Point	136℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Colorless to Pale Yellow Liquid
Assay / Analysis Method	≥98.0% (GC)
Ethyl 4-Chloroacetoacetate	≤0.30%
Moisture (K.F)	≤0.30%
Dichloromethane	≤0.50%
Ethanol	≤1.50%
pH	5.0~7.0
Test Standard	Enterprise Standard
Usage	Pharmaceutical Intermediate

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Ethyl 4-Chloro-3-Hydroxybutanoate (CAS: 10488-69-4) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and Active Pharmaceutical Ingredient (API) synthesis.

Ethyl 4-Chloro-3-Hydroxybutanoate (CAS: 10488-69-4) is a key chiral intermediate in statins. It is an intermediate of Olacetam, Olacetam in the treatment of alzheimer's disease. Ethyl 4-Chloro-3-Hydroxybutanoate (CAS: 10488-69-4), it is an important organic intermediate to synthesize precursor compounds of cholesterol-lowering drugs, but also for many activities synthesis of drugs such as hydroxymethylglutaryl reductase inhibitors and 1,4-dihydropyridine β-blockers. It has the advantage of being easy to synthesize and inexpensive, and it is a very cost-effective way to prepare Ethyll-4-Chloro-3-Hydroxy Butyrate by asymmetric reduction as a reaction raw material.